March 7, 2017 / 7:45 AM / 7 months ago

BRIEF-Immunovia: Final study data confirms effectiveness of IMMray

March 7 (Reuters) - Immunovia AB (publ):

* Says final data from major Swedish study confirms that IMMray biomarker microarray differentiates SLE from other autoimmune diseases with 96 pct accuracy

* In first arm of study, SLE was detected with accuracy as high as 95 pct from RA sample cohort and 99 pct from healthy controls

* In second arm of study, SLE could be differentiated from pool of samples of all three other autoimmune diseases with an accuracy of 96 pct

* Says is now proceeding closely with several key opinion leaders on designing validation of IMMray biomarker signatures in larger retrospective and prospective trials Source text: bit.ly/2mQHEp3 Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below